Cargando…
Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
Thrombosis, a major cause of deaths in this modern era responsible for 31% of all global deaths reported by WHO in 2017, is due to the aggregation of fibrin in blood vessels which leads to myocardial infarction or other cardiovascular diseases (CVDs). Classical agents such as anti-platelet, anti-coa...
Autores principales: | Altaf, Farwa, Wu, Shourong, Kasim, Vivi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194080/ https://www.ncbi.nlm.nih.gov/pubmed/34124160 http://dx.doi.org/10.3389/fmolb.2021.680397 |
Ejemplares similares
-
A Novel Fibrinolytic Protein From Pheretima vulgaris: Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation
por: Liu, Hai, et al.
Publicado: (2022) -
Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role
por: Singh, Rajni, et al.
Publicado: (2023) -
The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy
por: Yuan, Meiqin, et al.
Publicado: (2022) -
NAD(+) Degrading Enzymes, Evidence for Roles During Infection
por: Tan, Arnold, et al.
Publicado: (2021) -
The role of structural dynamics in the thermal adaptation of hyperthermophilic enzymes
por: Fusco, Giuliana, et al.
Publicado: (2022)